Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Young Suk Lee 2 Articles
Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor
Su Hwa Kim, Young Suk Lee, Sung Hak Lee, Yeoun Eun Sung, Ahwon Lee, Jun Kang, Jae-Sung Park, Sin Soo Jeun, Youn Soo Lee
J Pathol Transl Med. 2023;57(4):217-231.   Published online July 11, 2023
DOI: https://doi.org/10.4132/jptm.2023.06.10
  • 1,207 View
  • 113 Download
AbstractAbstract PDF
Background
The metastatic brain tumor is the most common brain tumor. The aim of this study was to demonstrate the clinicopathological and molecular pathologic features of brain metastases (BM).
Methods
A total of 269 patients were diagnosed with BM through surgical resection at Seoul St. Mary’s Hospital from January 2010 to March 2020. We reviewed the clinicopathological features and molecular status of primary and metastatic brain tissues using immunohistochemistry and molecular pathology results.
Results
Among 269 patients, 139 males and 130 females were included. The median age of primary tumor was 58 years (range, 13 to 87 years) and 86 patients (32.0%) had BM at initial presentation. Median BM free interval was 28.0 months (range, 1 to 286 months). The most frequent primary site was lung 46.5% (125/269), and followed by breast 15.6% (42/269), colorectum 10.0% (27/269). Epidermal growth factor receptor (EGFR) mutation was found in 50.8% (32/63) and 58.0% (40/69) of lung primary and BM, respectively. In both breast primary and breast cancer with BM, luminal B was the most frequent subtype at 37.9% (11/29) and 42.9% (18/42), respectively, followed by human epidermal growth factor receptor 2 with 31.0% (9/29) and 33.3% (14/42). Triple-negative was 20.7% (6/29) and 16.7% (7/42), and luminal A was 10.3% (3/29) and 7.1% (3/42) of breast primary and BM, respectively. In colorectal primary and colorectal cancer with BM, KRAS mutation was found in 76.9% (10/13) and 66.7% (2/3), respectively.
Conclusions
We report the clinicopathological and molecular pathologic features of BM that can provide useful information for understanding the pathogenesis of metastasis and for clinical trials based on the tumor’s molecular pathology.
Molecular characteristics of meningiomas
Young Suk Lee, Youn Soo Lee
J Pathol Transl Med. 2020;54(1):45-63.   Published online January 15, 2020
DOI: https://doi.org/10.4132/jptm.2019.11.05
  • 13,868 View
  • 561 Download
  • 31 Web of Science
  • 36 Crossref
AbstractAbstract PDF
Meningioma is the most common primary intracranial tumor in adults. The grading of meningioma is based on World Health Organization criteria, which rely on histopathological features alone. This grading system is unable to conclusively predict the clinical behavior of these tumors (i.e., recurrence or prognosis in benign or atypical grades). Advances in molecular techniques over the last decade that include genomic and epigenomic data associated with meningiomas have been used to identify genetic biomarkers that can predict tumor behavior. This review summarizes the molecular characteristics of meningioma using genetic and epigenetic biomarkers. Molecular alterations that can predict meningioma behavior may be integrated into the upcoming World Health Organization grading system.

Citations

Citations to this article as recorded by  
  • The Natural History and Treatment of Meningiomas: An Update
    Arsene Daniel Nyalundja, Fabrice Mugisha, Claire Karekezi
    Seminars in Neurology.2024; 44(01): 001.     CrossRef
  • Epidemiology, Genetics, and DNA Methylation Grouping of Hyperostotic Meningiomas
    Gray Umbach, Edwina B. Tran, Charlotte D. Eaton, Abrar Choudhury, Ramin Morshed, Javier E. Villanueva-Meyer, Philip V. Theodosopoulos, Stephen T. Magill, Michael W. McDermott, David R. Raleigh, Ezequiel Goldschmidt
    Operative Neurosurgery.2024;[Epub]     CrossRef
  • Recurrence of Resected Skull Base Meningiomas during Long-term Follow-up: Incidence and Predisposing Factors
    Joshua Ian Macarthur, Cathal John Hannan, Callum Howard, Jane Halliday, Omar Nathan Pathmanaban, Charlotte Hammerbeck-Ward, Scott A. Rutherford, Andrew T. King
    Journal of Neurological Surgery Part B: Skull Base.2024;[Epub]     CrossRef
  • The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care
    S. Joy Trybula, Mark W. Youngblood, Constantine L. Karras, Nikhil K. Murthy, Amy B. Heimberger, Rimas V. Lukas, Sean Sachdev, John A. Kalapurakal, James P. Chandler, Daniel J. Brat, Craig M. Horbinski, Stephen T. Magill
    Cancers.2024; 16(9): 1753.     CrossRef
  • DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups
    Jyotsna Singh, Ravi Sharma, Nidhi Shukla, Priya Narwal, Amit Katiyar, Swati Mahajan, Saumya Sahu, Ajay Garg, Mehar C. Sharma, Ashish Suri, Chitra sarkar, Vaishali Suri
    Journal of Neuro-Oncology.2023; 161(2): 339.     CrossRef
  • Spinal meningiomas, from biology to management - A literature review
    Nicolas Serratrice, Imène Lameche, Christian Attieh, Moussa A Chalah, Joe Faddoul, Bilal Tarabay, Rabih Bou-Nassif, Youssef Ali, Joseph G Mattar, François Nataf, Samar S Ayache, Georges N Abi Lahoud
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression
    Sarah A Cain, Bernard Pope, Stefano Mangiola, Theo Mantamadiotis, Katharine J Drummond
    BMC Cancer.2023;[Epub]     CrossRef
  • Actualización sobre el meningioma: correlación clínico-radiológica y radio-patológica
    A. Navarro-Ballester, M. Aleixandre-Barrachina, S.F. Marco-Doménech
    Radiología.2023; 65(5): 458.     CrossRef
  • SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome
    Erika Fiorentini, Laura Giunti, Andrea Di Rita, Simone Peraio, Carla Fonte, Chiara Caporalini, Anna Maria Buccoliero, Maria Luigia Censullo, Giulia Gori, Alice Noris, Rosa Pasquariello, Roberta Battini, Rossana Pavone, Flavio Giordano, Sabrina Giglio, Ber
    European Journal of Medical Genetics.2023; 66(7): 104784.     CrossRef
  • Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas
    Liguo Ye, Shi’ao Tong, Yaning Wang, Yu Wang, Wenbin Ma
    Journal of Cancer Research and Clinical Oncology.2023; 149(12): 9857.     CrossRef
  • Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers
    A. Basit Khan, Rajan Patel, Malcolm F. McDonald, Eric Goethe, Collin English, Ron Gadot, Arya Shetty, Shervin Hosseingholi Nouri, Arif O. Harmanci, Akdes S. Harmanci, Tiemo J. Klisch, Akash J. Patel
    Journal of Neuro-Oncology.2023; 163(2): 397.     CrossRef
  • DNA methylation meningioma biomarkers: attributes and limitations
    Zhaohui Li, Yufei Gao, Jinnan Zhang, Liang Han, Hang Zhao
    Frontiers in Molecular Neuroscience.2023;[Epub]     CrossRef
  • Meningioma: A Biography—Tumor Forever Tied to the Origins and “Soul of Neurosurgery”
    Nolan J. Brown, Zach Pennington, Cathleen C. Kuo, Julian Gendreau, Sachiv Chakravarti, Rohin Singh, Dontré M. Douse, Jamie J. Van Gompel
    World Neurosurgery.2023; 178: 191.     CrossRef
  • Molecular genetic features of meningiomas
    E.S. Makashova, N.V. Lasunin, M.V. Galkin, S.V. Zolotova, K.O. Karandasheva, A.V. Golanov
    Voprosy neirokhirurgii imeni N.N. Burdenko.2023; 87(4): 101.     CrossRef
  • Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications
    Gerardo Caruso, Rosamaria Ferrarotto, Antonello Curcio, Luisa Metro, Francesco Pasqualetti, Paola Gaviani, Valeria Barresi, Filippo Flavio Angileri, Maria Caffo
    Cancers.2023; 15(18): 4521.     CrossRef
  • Update on meningioma: Clinical-radiological and radio-pathological correlation
    A. Navarro-Ballester, M. Aleixandre-Barrachina, S.F. Marco-Doménech
    Radiología (English Edition).2023; 65(5): 458.     CrossRef
  • Early Preventive Strategies and CNS Meningioma – Is This Feasible? A Comprehensive Review of the Literature
    Daniel Sescu, Aminta Chansiriwongs, Katarzyna Julia Minta, Jyothi Vasudevan, Chandrasekaran Kaliaperumal
    World Neurosurgery.2023; 180: 123.     CrossRef
  • Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas
    Michele Tomanelli, Tullio Florio, Gabriela Vargas, Aldo Pagano, Paola Modesto
    Life.2023; 13(12): 2284.     CrossRef
  • The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications
    Stephanie M. Robert, Shaurey Vetsa, Arushii Nadar, Sagar Vasandani, Mark W. Youngblood, Evan Gorelick, Lan Jin, Neelan Marianayagam, E Zeynep Erson-Omay, Murat Günel, Jennifer Moliterno
    Journal of Neuro-Oncology.2022; 156(2): 205.     CrossRef
  • Clinical presentation, diagnostic findings and outcome of dogs undergoing surgical resection for intracranial meningioma: 101 dogs
    Alexander K. Forward, Holger Andreas Volk, Giunio Bruto Cherubini, Tom Harcourt-Brown, Ioannis N. Plessas, Laurent Garosi, Steven De Decker
    BMC Veterinary Research.2022;[Epub]     CrossRef
  • Sphenoid wing meningiomas: peritumoral brain edema as a prognostic factor in surgical outcome
    Abdalrahman Nassar, Volodymyr Smolanka, Andriy Smolanka, Dipak Chaulagain, Oleg Devinyak
    Neurosurgical Review.2022; 45(4): 2951.     CrossRef
  • Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature
    Wenjie Peng, Pei Wu, Minghao Yuan, Bo Yuan, Lian Zhu, Jiesong Zhou, Qian Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Case Report: Upper Thoracic Purely Extradural Spinal Meningioma With Nerve Root Attachment: A Case Report and Literature Review
    Zhao-Lin Wang, Jian-Hui Mou, Dong Sun, Peng Liu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)
    Jiaojiao Deng, Lingyang Hua, Liuguan Bian, Hong Chen, Ligang Chen, Hongwei Cheng, Changwu Dou, Dangmurenjiapu Geng, Tao Hong, Hongming Ji, Yugang Jiang, Qing Lan, Gang Li, Zhixiong Liu, Songtao Qi, Yan Qu, Songsheng Shi, Xiaochuan Sun, Haijun Wang, Yongpi
    Chinese Medical Journal.2022; 135(16): 1894.     CrossRef
  • Оновлена інформація про менінгіоми крила клиноподібної кістки
    Abdalrahman Nassar, Volodymyr Smolanka
    INTERNATIONAL NEUROLOGICAL JOURNAL.2022; 18(1): 43.     CrossRef
  • The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas
    Rahmina Meta, Henning B. Boldt, Bjarne W. Kristensen, Felix Sahm, Wenche Sjursen, Sverre H. Torp
    Cancers.2021; 13(6): 1262.     CrossRef
  • Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
    Suha Bachir, Sanjit Shah, Scott Shapiro, Abigail Koehler, Abdelkader Mahammedi, Ravi N. Samy, Mario Zuccarello, Elizabeth Schorry, Soma Sengupta
    International Journal of Molecular Sciences.2021; 22(2): 690.     CrossRef
  • Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions
    Christian Ogasawara, Brandon D. Philbrick, D. Cory Adamson
    Biomedicines.2021; 9(3): 319.     CrossRef
  • The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma
    Minsun Jung, Seong-Ik Kim, Ka Young Lim, Jeongmo Bae, Chul-Kee Park, Seung Hong Choi, Sung-Hye Park, Jae-Kyung Won
    Human Pathology.2021; 115: 96.     CrossRef
  • Papillary Meningioma: Case Presentation with Emphasis on Surgical and Medical Therapy of a Rare Variant of Meningioma
    Gerardo Cazzato, Valeria Internò, Antonietta Cimmino, Raffaella Messina, Marco Tucci, Teresa Lettini, Leonardo Resta, Giuseppe Ingravallo
    Diseases.2021; 9(3): 63.     CrossRef
  • An Overview of Managements in Meningiomas
    Lianhua Zhao, Wei Zhao, Yanwei Hou, Cuixia Wen, Jing Wang, Pei Wu, Zaiyu Guo
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Multi-Omics Analysis in Initiation and Progression of Meningiomas: From Pathogenesis to Diagnosis
    Jiachen Liu, Congcong Xia, Gaiqing Wang
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Molecular Mechanism and Approach in Progression of Meningioma
    Zhiwei Shao, Lihong Liu, Yanghao Zheng, Sheng Tu, Yuanbo Pan, Sheng Yan, Qichun Wei, Anwen Shao, Jianmin Zhang
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences
    Andres Ramos-Fresnedo, Ricardo A. Domingo, Tito Vivas-Buitrago, Larry Lundy, Daniel M. Trifiletti, Mark E. Jentoft, Amit B. Desai, Alfredo Quiñones-Hinojosa
    Journal of Neuro-Oncology.2020; 149(3): 413.     CrossRef
  • Meningioma: A Review of Clinicopathological and Molecular Aspects
    Kristin Huntoon, Angus Martin Shaw Toland, Sonika Dahiya
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Neues zur Einteilung und Therapie von Meningeomen
    Corinna Seliger, Wolfgang Wick
    Neurologie up2date.2020; 3(04): 343.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine